Alivus Life Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alivus Life Sciences has informed the stock exchange that its trading window is being closed in line with SEBI's Insider Trading Regulations, 2015. During this period, company insiders such as directors, key managerial personnel, and designated employees are prohibited from buying or selling shares of the company. Trading window closures typically take place ahead of board meetings where financial results or other price-sensitive matters are discussed. The window will reopen once the unpublished price-sensitive information is made public. This is a routine regulatory compliance filing and does not by itself indicate any specific corporate event, though it often precedes the announcement of quarterly or annual financial results.
This is a routine compliance measure with no direct impact on the stock price, but it signals that a material announcement—most likely upcoming financial results—may be released once the trading window reopens.